Vimta Labs Ltd Share Price

Overview

Vimta Labs Ltd share price is currently ₹617.16, down by - ₹0.52 (0.08%) from its previous closing price of ₹617.68. The share price has declined -2.6% over the past month and declined -23.41% over the past year. The stock's 52-week low and high are ₹0.00 and ₹843.14, respectively. Vimta Labs Ltd has a market capitalisation of ₹ 2,840.00 Cr. The share price was last updated on 09 Sep 2026, 03:50 PM IST.

Vimta Labs Ltd
Vimta Labs Ltd
VIMTALABS
 0.00
- 0.52
0.08%
Healthcare
 0.00(%)1D

Updated: 09 Sep 2026, 03:50:39 pm IST

Market Data

Open Price

 614.00

Prev. Close

 617.68
 606.16

Day Low

 627.94

Day High

 0.00

52 Week Low

 843.14

52 Week High

HealthcareBusiness Support
CategorySmall Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

34.57

Sector PE

42.03

PB Ratio

6.13

Sector PB

5.73

EPS

17.85

Dividend Yield

0.53

Today's Volume

176.213 K

5 Day Avg. Volume

199.347 K

PEG Ratio

-0.82

Market Cap.

₹ 2,840.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsFinal Dividend of 100% at ₹2/Share
18-Jun-202618-Jun-2026
Bonus1:1
13-Jun-202513-Jun-2025
DividendsFinal Dividend of 100% at ₹2/Share
30-May-202530-May-2025

Mutual Fund Ownership

Mutual Fund Holder
Jun 26
Shares held
Jul 26
Shares held
WhiteOak Capital Pharma and Healthcare Fund - Regular Plan - Growth88.50 k
1.03 Lac
(16.21%)
Motilal Oswal BSE Healthcare ETF407
416
(2.21%)
Bandhan BSE Healthcare Index Fund - Regular Plan - Growth208
223
(7.21%)

About Vimta Labs Ltd 👋

Vimta Labs Limited is an India-based contract research and testing services provider. The Company operates through the Contract Research and Testing Services segment. It is engaged in providing a range of services to biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, power, cement, oil and gas, ore and minerals, infrastructure and many other industries, government organizations as well as other industry participants. Its services include drug discovery, development, and drug life cycle management support services; preclinical research and testing services for medical device companies; contract research and testing for agrochemical and specialty chemical companies; food testing and analytical development services to support manufacturers, processors, farmers, and retailers; contact research and development of biologics and peptides and electrical/electronic safety, environmental and physical security products testing.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
InvestAce Capital

InvestAce Capital

7 Aug • 1:36 PM · SEBI-Registered Analyst

Every Growing Economy Needs Someone to Verify It.

Growth creates transactions. Transactions create the need for trust. Whether it's a medical test, a credit rating, a product certification, an ESG audit or a financial statement, verification becomes more valuable as the economy scales. That's why businesses built around independent validation often enjoy long growth runways.

CRISIL
verifies credit risk.
VIMTALABS
validates products through testing.
METROPOLIS
and !Dr Lal PathLabs verify health through diagnostics. TÜV SÜD India (unlisted) and global certification firms play a similar role in industrial compliance. The bigger an economy becomes, the more important verification becomes. Trust isn't just an outcome of growth. It's an industry in itself.

See More
InvestAce Capital

InvestAce Capital

28 Jul • 10:20 AM · SEBI-Registered Analyst

The Best Businesses Sell Peace of Mind.

Some products are bought because customers want them. Others are bought because customers can't afford the consequences of not buying them. A hospital can't compromise on Poly Medicure's medical devices. A pharmaceutical company can't skip Vimta Labs' testing. A power utility can't risk a transformer failure supplied by

POWERINDIA
or Shilchar Technologies. An FMCG company can't ignore the integrity of packaging from
TCPLPACK
. These companies aren't selling products. They're selling reliability, compliance and risk reduction. And businesses built around reducing risk often enjoy stronger pricing power than businesses built around adding convenience.

See More
InvestAce Capital

InvestAce Capital

26 Jul • 12:27 PM · SEBI-Registered Analyst

Every Industry Has a "Toll Booth.

Not every company has to win the market. Some just have to be present every time the market grows. Every IPO passes through

CDSL
. Every mutual fund folio is serviced by
CAMS
or
KFINTECH
. Every exported pharmaceutical product undergoes testing by companies like Vimta Labs. Every packaged product needs companies like
TCPLPACK
or
UFLEX
before it reaches the shelf. These businesses don't need to predict which customer will succeed. They simply collect their share as the ecosystem expands. That's often where the most consistent compounders are found.

See More
InvestAce Capital

InvestAce Capital

21 Jul • 5:09 PM · SEBI-Registered Analyst

Water Testing Could Become the Next Compliance Opportunity.

India is investing heavily in drinking water, wastewater treatment and industrial infrastructure. But building pipelines and treatment plants is only half the job. Water quality has to be tested, monitored and certified on a regular basis. As environmental regulations tighten and industries face stricter compliance requirements, demand for testing, analytical instruments and water quality solutions could rise alongside infrastructure spending.

WABAG
,
IONEXCHANG
,
VIMTALABS
,
SHRIPISTON
(through emission and testing-related components in industrial applications), and !Agro Tech Foods (limited food quality testing exposure) touch different parts of the broader quality and compliance ecosystem, though Vimta Labs has the most direct exposure to testing services.

See More
InvestAce Capital

InvestAce Capital

8 Jul • 3:58 PM · SEBI-Registered Analyst

The Hidden Beneficiaries of India's Laboratory Boom

Everyone is talking about pharma and electronics manufacturing. Few are looking at the laboratories behind them. As India expands into semiconductors, specialty chemicals, pharmaceuticals and defence manufacturing, demand for testing, calibration and analytical laboratories is rising rapidly. Every new plant needs certified testing before products reach customers. Companies like Agilent Technologies India (parent listed globally), while listed Indian beneficiaries include

LAURUSLABS
,
DIVISLAB
,
VIMTALABS
, and
SHILPAMED
, which continue to invest heavily in testing and quality infrastructure.

See More
Unite Technologies Financial

Unite Technologies Financial

5 May • 11:58 PM · SEBI-Registered Analyst

Technical Analysis Vimta Labs Limited.

The stock

VIMTALABS
after a massive rally that peaked near the 880-900 zone late last year the stock entered a long and steep downtrend. However the current daily chart shows that this downtrend has paused and a strong short-term recovery is now in progress. Immediate Support the first major support is now around the ₹440–₹450 level the recent minor pullback area. The ultimate strong base remains the ₹380–₹400 zone. Immediate Resistance on the upside the stock is approaching its next hurdle near the ₹520 to ₹560 zone. This area saw a lot of price action during the previous fall and will likely act as a resistance level now. For short-term buyers the current upward momentum is attractive, offering a potential entry with a strict stop loss below the ₹440 support zone to play the move toward the ₹520–₹560 resistance. Current holders who bought at the bottom should trail their stop losses upward to protect their recent profits as the price approaches the psychological ₹500 mark. Meanwhile investors holding from higher levels can continue to hold as the solid base formation near ₹400 suggests the heaviest selling phase has ended. Technical analysis is based on historical patterns and does not guarantee future results. Always use a Stop-Loss to manage your risk.

See More

News & Events

Frequently Asked Questions

What is the share price of Vimta Labs Ltd?

What is the market cap of Vimta Labs Ltd?

Should I buy Vimta Labs Ltd stock now?

What is the 52 week high and low of Vimta Labs Ltd?

Is the Vimta Labs Ltd stock good to buy?

Is Vimta Labs Ltd a good buy for the long term?

Is Vimta Labs Ltd overvalued or undervalued?

What is the PE and PB ratio of Vimta Labs Ltd?

Start Now